PAQ Therapeutics Raises $77M, Doses First in PT0511 Phase 1
22 Jan 2026 //
PR NEWSWIRE
PAQ Therapeutics Raises $39M in Series B, Starts Phase 1 Trial
07 May 2025 //
PR NEWSWIRE
PAQ Therapeutics Collaborate with Insilico Medicine to Develop Novel Therapies
09 Sep 2021 //
BIOSPACE

Market Place
Sourcing Support